110

Bioinformatics of the Brain

[169] M. Ingram, G. B. Techy, and R. Saroufeem et al., “Three-dimensional

growth patterns of various human tumor cell lines in simulated mi-

crogravity of a NASA bioreactor,” In Vitro Cellular & Developmental

Biology-Animal, vol. 33, pp. 459–466, 1997.

[170] S. A. Abdul Rahim, A. Dirkse, and A. Oudin et al., “Regulation of

hypoxia-induced autophagy in glioblastoma involves ATG9A,” British

Journal of Cancer, vol. 117, no. 6, pp. 813–825, 2017.

[171] D. Fanfone, A. Idbaih, and J. Mammi et al., “Profiling anti-apoptotic

BCL-xL protein expression in glioblastoma tumorspheres,” Cancers,

vol. 12, no. 10, p. 2853, 2020.

[172] X. Cai, R. G. Briggs, and H. B. Homburg et al., “Application of microflu-

idic devices for glioblastoma study: current status and future directions,”

Biomedical Microdevices, vol. 22, p. 60, 2020.

[173] J. Ma, N. Li, and Y. Wang et al., “Engineered 3D tumour model for

study of glioblastoma aggressiveness and drug evaluation on a detach-

ably assembled microfluidic device,” Biomedical microdevices, vol. 20,

no. 3, p. 80, 2018.

[174] J. M. Ayuso, M. Virumbrales-Muñoz, and A. Lacueva et al., “Develop-

ment and characterization of a microfluidic model of the tumour mi-

croenvironment,” Scientific Reports, vol. 6, no. 1, p. 36086, 2016.

[175] H.-G. Yi, Y. H. Jeong, and Y. Kim et al., “A bioprinted human-

glioblastoma-on-a-chip for the identification of patient-specific responses

to chemoradiotherapy,” Nature Biomedical Engineering, vol. 3, no. 7,

pp. 509–519, 2019.

[176] L. Neufeld, E. Yeini, and N. Reisman et al., “Microengineered perfus-

able 3D-bioprinted glioblastoma model for in vivo mimicry of tumor

microenvironment,” Science Advances, vol. 7, no. 34, p. eabi9119, 2021.

[177] N. Minami, Y. Maeda, and S. Shibao et al., “Organotypic brain explant

culture as a drug evaluation system for malignant brain tumors,” Cancer

Medicine, vol. 6, no. 11, pp. 2635–2645, 2017.

[178] M. A. Marques-Torrejon, E. Gangoso, and S. M. Pollard, “Modelling

glioblastoma tumour-host cell interactions using adult brain organ-

otypic slice co-culture,” Disease Models & Mechanisms, vol. 11, no. 2,

p. dmm031435, 2018.

[179] A. B. Satterlee, D. E. Dunn, and D. C. Lo et al., “Tumoricidal stem cell

therapy enables killing in novel hybrid models of heterogeneous glioblas-

toma,” Neuro-Oncology, vol. 21, no. 12, pp. 1552–1564, 2019.